Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Pulse Biosciences Inc PLSE

Healthcare Medical Devices

Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it... see more

Add To Watchlist

Recent & Breaking News (NDAQ:PLSE)

Pulse Biosciences, Inc. Announces Oversubscription, Pricing and Preliminary Results for Its $45 Million Rights Offering

Business Wire December 7, 2018

Pulse Biosciences, Inc. Announces Commencement of Rights Offering

Business Wire November 19, 2018

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire November 15, 2018

Pulse Biosciences, Inc. Announces Record Date, Subscription Pricing, and Expiration Date for Rights Offering and Effectiveness of Its Registration Statement

Business Wire November 7, 2018

Report: Developing Opportunities within Pulse Biosciences, Baxter International, FirstEnergy, Affiliated Managers Group, Baidu, and Shopify — Future Expectations, Projections Moving into 2018

GlobeNewswire November 2, 2018

Pulse Biosciences Quarterly Investor Conference Call

Business Wire October 30, 2018

Pulse Biosciences Files Registration Statement for Rights Offering

Business Wire October 25, 2018

Pulse Biosciences to Report Third Quarter 2018 and Operational Highlights and Financial Results

Business Wire October 23, 2018

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire October 15, 2018

Pulse Biosciences Announces Continued Expansion of Its Clinical Study Programs in Dermatology

Business Wire October 11, 2018

Pulse Biosciences to Present at the Cantor Global Healthcare Conference

Business Wire October 1, 2018

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire September 19, 2018

Robbins Arroyo LLP Is Investigating the Officers and Directors of Pulse Biosciences, Inc. (PLSE) on Behalf of Shareholders

Business Wire August 13, 2018

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire August 3, 2018

Pulse Biosciences Quarterly Investor Conference Call

Business Wire July 31, 2018

Pulse Biosciences Treats Initial Patient in Its Human Study Evaluating the Effects of Nano-Pulse Stimulation in Basal Cell Carcinoma

Business Wire July 30, 2018

Pulse Biosciences to Report Second Quarter 2018 Financial Results and Operational Highlights

Business Wire July 12, 2018

Pulse Biosciences Announces Treatment of First Patients in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation for the Treatment of Sebaceous Hyperplasia Lesions

Business Wire July 10, 2018

Robbins Arroyo LLP Is Investigating the Officers and Directors of Pulse Biosciences, Inc. (PLSE) on Behalf of Shareholders

Business Wire June 25, 2018

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire June 25, 2018